Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quarterly Newsletter Release

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Feb 25, 2022 10:53am

542 Views

Post# 34461444

RE:RE:RE:Quarterly Newsletter Release

I think there are 7 new patients for the first 3 month data in the next letter. My hope is at least 4 of them are doing a happy dance. 5 will make me do a happy dance. Bad hip and all. With a little luck, next week is show time. I hope there is no Friday after the close release though. Ugh! Good luck everyone.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market